More companies have released information on presentations related to their pipelines and new data at the ARVO 2024 conference ...

The data will be presented in oral session at the 2024 American Society of Gene & Cell Therapy meeting May 7-11 in Baltimore, ...

The verdict was announced on April 26, following a 5-day trial by jury. According to a press release from Sight Sciences, the ...

Joseph Izatt was a skilled researcher and inventor who played a foundational role in the development of optical coherence ...

George O. Waring IV, MD, FACS, highlighted preliminary data from an open-label clinical trial, where his site was 1 of 4 in ...

The module encompasses real world data on more than 250,000 de-identified patients and provides information on extracting ...

Neda Nikpoor, MD, urges audience members to become more empowered in making small but meaningful, evidence-based changes in ...

David Hutton, Managing Editor of Ophthalmology Times sat down with Claris Bio CEO, Clarke Atwell, to discuss the company's ...

Deborah Gess Ristvedt, DO, shares highlights from her presentation and what these real-world cases mean for clinicians and ...

Program cochair Arjan Hura, MD, previews this year’s extended schedule with discussions on retina gene therapies, corneal ...

According to the company, a subretinal injection of ATSN-201 was well tolerated in all patients in the first cohort with extensive resolution of schisis observed in 2 patients. Safety data from the ...

The system is comprised of 25 miniaturized wireless stimulators with 400 electrodes that are implanted permanently.